Cellular and molecular mechanisms of muscle atrophy

DMM Disease Models and Mechanisms - Tập 6 Số 1 - Trang 25-39 - 2013
Paolo Bonaldo1, Marco Sandri1,2
1Department of Biomedical Sciences, University of Padova, 35131 Padova, Italy
2Dulbecco Telethon Institute, Venetian Institute of Molecular Medicine, 35129 Padova, Italy

Tóm tắt

Skeletal muscle is a plastic organ that is maintained by multiple pathways regulating cell and protein turnover. During muscle atrophy, proteolytic systems are activated, and contractile proteins and organelles are removed, resulting in the shrinkage of muscle fibers. Excessive loss of muscle mass is associated with poor prognosis in several diseases, including myopathies and muscular dystrophies, as well as in systemic disorders such as cancer, diabetes, sepsis and heart failure. Muscle loss also occurs during aging. In this paper, we review the key mechanisms that regulate the turnover of contractile proteins and organelles in muscle tissue, and discuss how impairments in these mechanisms can contribute to muscle atrophy. We also discuss how protein synthesis and degradation are coordinately regulated by signaling pathways that are influenced by mechanical stress, physical activity, and the availability of nutrients and growth factors. Understanding how these pathways regulate muscle mass will provide new therapeutic targets for the prevention and treatment of muscle atrophy in metabolic and neuromuscular diseases.

Từ khóa


Tài liệu tham khảo

Allen, 2007, Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors, Am. J. Physiol. Cell. Physiol., 292, C188, 10.1152/ajpcell.00542.2005

Amirouche, 2009, Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle, Endocrinology, 150, 286, 10.1210/en.2008-0959

Amthor, 2009, Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity, Proc. Natl. Acad. Sci. USA, 106, 7479, 10.1073/pnas.0811129106

Arndt, 2010, Chaperone-assisted selective autophagy is essential for muscle maintenance, Curr. Biol., 20, 143, 10.1016/j.cub.2009.11.022

Baehr, 2011, Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids, J. Physiol., 589, 4759, 10.1113/jphysiol.2011.212845

Bello, 2009, The E3 ubiquitin ligase specificity subunit ASB2beta is a novel regulator of muscle differentiation that targets filamin B to proteasomal degradation, Cell Death Differ., 16, 921, 10.1038/cdd.2009.27

Bentzinger, 2008, Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy, Cell Metab., 8, 411, 10.1016/j.cmet.2008.10.002

Bernardi, 2008, Dysfunction of mitochondria and sarcoplasmic reticulum in the pathogenesis of collagen VI muscular dystrophies, Ann. N. Y. Acad. Sci., 1147, 303, 10.1196/annals.1427.009

Bertaggia, 2012, Posttranslational modifications control FoxO3 activity during denervation, Am. J. Physiol. Cell. Physiol., 302, C587, 10.1152/ajpcell.00142.2011

Blaauw, 2009, Inducible activation of Akt increases skeletal muscle mass and force without satellite cell activation, FASEB J., 23, 3896, 10.1096/fj.09-131870

Bodine, 2001, Identification of ubiquitin ligases required for skeletal muscle atrophy, Science, 294, 1704, 10.1126/science.1065874

Bodine, 2001, Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo, Nat. Cell Biol., 3, 1014, 10.1038/ncb1101-1014

Bothe, 2000, Selective expression of Cre recombinase in skeletal muscle fibers, Genesis, 26, 165, 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F

Brault, 2010, Peroxisome proliferator-activated receptor gamma coactivator 1alpha or 1beta overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse atrophy, J. Biol. Chem., 285, 19460, 10.1074/jbc.M110.113092

Cai, 2004, IKKbeta/NF-kappaB activation causes severe muscle wasting in mice, Cell, 119, 285, 10.1016/j.cell.2004.09.027

Calnan, 2008, The FoxO code, Oncogene, 27, 2276, 10.1038/onc.2008.21

Carmignac, 2011, Autophagy is increased in laminin α2 chain-deficient muscle and its inhibition improves muscle morphology in a mouse model of MDC1A, Hum. Mol. Genet., 20, 4891, 10.1093/hmg/ddr427

Caron, 2011, The proteasome inhibitor MG132 reduces immobilization-induced skeletal muscle atrophy in mice, BMC Musculoskelet. Disord., 12, 185, 10.1186/1471-2474-12-185

Chang, 2012, Bcl-2-associated autophagy regulator Naf-1 required for maintenance of skeletal muscle, Hum. Mol. Genet., 21, 2277, 10.1093/hmg/dds048

Clarke, 2007, The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle, Cell Metab., 6, 376, 10.1016/j.cmet.2007.09.009

Clop, 2006, A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep, Nat. Genet., 38, 813, 10.1038/ng1810

Cohen, 2009, During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation, J. Cell Biol., 185, 1083, 10.1083/jcb.200901052

Cohen, 2012, Ubiquitylation by Trim32 causes coupled loss of desmin, Z-bands, and thin filaments in muscle atrophy, J. Cell Biol., 198, 575, 10.1083/jcb.201110067

Combaret, 2005, USP19 is a ubiquitin-specific protease regulated in rat skeletal muscle during catabolic states, Am. J. Physiol. Endocrinol. Metab., 288, E693, 10.1152/ajpendo.00281.2004

Cong, 2011, Inhibition of atrogin-1/MAFbx expression by adenovirus-delivered small hairpin RNAs attenuates muscle atrophy in fasting mice, Hum. Gene Ther., 22, 313, 10.1089/hum.2010.057

Csibi, 2010, The translation regulatory subunit eIF3f controls the kinase-dependent mTOR signaling required for muscle differentiation and hypertrophy in mouse, PLoS ONE, 5, e8994, 10.1371/journal.pone.0008994

Cuervo, 2008, Autophagy and aging: keeping that old broom working, Trends Genet., 24, 604, 10.1016/j.tig.2008.10.002

de Alvaro, 2004, Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner, J. Biol. Chem., 279, 17070, 10.1074/jbc.M312021200

Demontis, 2010, FOXO/4E-BP signaling in Drosophila muscles regulates organism-wide proteostasis during aging, Cell, 143, 813, 10.1016/j.cell.2010.10.007

Deval, 2001, Identification of cathepsin L as a differentially expressed message associated with skeletal muscle wasting, Biochem. J., 360, 143, 10.1042/bj3600143

Dobrowolny, 2008, Skeletal muscle is a primary target of SOD1G93A-mediated toxicity, Cell Metab., 8, 425, 10.1016/j.cmet.2008.09.002

Dogra, 2007, TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine, FASEB J., 21, 1857, 10.1096/fj.06-7537com

Durieux, 2007, Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression, Endocrinology, 148, 3140, 10.1210/en.2006-1500

Fernández, 2002, Muscle-specific inactivation of the IGF-I receptor induces compensatory hyperplasia in skeletal muscle, J. Clin. Invest., 109, 347, 10.1172/JCI0213503

Fielitz, 2007, Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3, J. Clin. Invest., 117, 2486, 10.1172/JCI32827

Fukuda, 2006, Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease, Ann. Neurol., 59, 700, 10.1002/ana.20807

Fukuda, 2006, Autophagy and lysosomes in Pompe disease, Autophagy, 2, 318, 10.4161/auto.2984

Furuno, 1990, Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy, J. Biol. Chem., 265, 8550, 10.1016/S0021-9258(19)38923-9

Geng, 2011, PGC-1α promotes nitric oxide antioxidant defenses and inhibits FOXO signaling against cardiac cachexia in mice, Am. J. Pathol., 178, 1738, 10.1016/j.ajpath.2011.01.005

Gomes, 2001, Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy, Proc. Natl. Acad. Sci. USA, 98, 14440, 10.1073/pnas.251541198

Gomis, 2006, A FoxO-Smad synexpression group in human keratinocytes, Proc. Natl. Acad. Sci. USA, 103, 12747, 10.1073/pnas.0605333103

Goncalves, 2010, Akt deficiency attenuates muscle size and function but not the response to ActRIIB inhibition, PLoS ONE, 5, e12707, 10.1371/journal.pone.0012707

Greer, 2007, An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans, Curr. Biol., 17, 1646, 10.1016/j.cub.2007.08.047

Greer, 2007, The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor, J. Biol. Chem., 282, 30107, 10.1074/jbc.M705325200

Grobet, 2003, Modulating skeletal muscle mass by postnatal, muscle-specific inactivation of the myostatin gene, Genesis, 35, 227, 10.1002/gene.10188

Grumati, 2010, Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration, Nat. Med., 16, 1313, 10.1038/nm.2247

Grumati, 2011, Autophagy induction rescues muscular dystrophy, Autophagy, 7, 426, 10.4161/auto.7.4.14392

Grumati, 2011, Physical exercise stimulates autophagy in normal skeletal muscles but is detrimental for collagen VI-deficient muscles, Autophagy, 7, 1415, 10.4161/auto.7.12.17877

Hanna, 2012, Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy, J. Biol. Chem., 287, 19094, 10.1074/jbc.M111.322933

Hara, 2006, Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice, Nature, 441, 885, 10.1038/nature04724

He, 2012, Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis, Nature, 481, 511, 10.1038/nature10758

Hirosumi, 2002, A central role for JNK in obesity and insulin resistance, Nature, 420, 333, 10.1038/nature01137

Hishiya, 2006, A novel ubiquitin-binding protein ZNF216 functioning in muscle atrophy, EMBO J., 25, 554, 10.1038/sj.emboj.7600945

Huang, 2007, Dynamic FoxO transcription factors, J. Cell Sci., 120, 2479, 10.1242/jcs.001222

Hunter, 2004, Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy, J. Clin. Invest., 114, 1504, 10.1172/JCI200421696

Izumiya, 2008, Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice, Cell Metab., 7, 159, 10.1016/j.cmet.2007.11.003

Jamart, 2011, Prevention of muscle disuse atrophy by MG132 proteasome inhibitor, Muscle Nerve, 43, 708, 10.1002/mus.21949

Judge, 2007, Role for IkappaBalpha, but not c-Rel, in skeletal muscle atrophy, Am. J. Physiol. Cell. Physiol., 292, C372, 10.1152/ajpcell.00293.2006

Kamei, 2004, Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control, J. Biol. Chem., 279, 41114, 10.1074/jbc.M400674200

Kedar, 2004, Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I, Proc. Natl. Acad. Sci. USA, 101, 18135, 10.1073/pnas.0404341102

Kirkin, 2009, A role for NBR1 in autophagosomal degradation of ubiquitinated substrates, Mol. Cell, 33, 505, 10.1016/j.molcel.2009.01.020

Kitamura, 2007, A Foxo/Notch pathway controls myogenic differentiation and fiber type specification, J. Clin. Invest., 117, 2477, 10.1172/JCI32054

Kline, 2007, Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol, J. Appl. Physiol., 102, 740, 10.1152/japplphysiol.00873.2006

Klionsky, 2008, Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes, Autophagy, 4, 151, 10.4161/auto.5338

Komatsu, 2007, Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice, Cell, 131, 1149, 10.1016/j.cell.2007.10.035

Kon, 2010, Chaperone-mediated autophagy in health and disease, FEBS Lett., 584, 1399, 10.1016/j.febslet.2009.12.025

Kudryashova, 2012, Satellite cell senescence underlies myopathy in a mouse model of limb-girdle muscular dystrophy 2H, J. Clin. Invest., 122, 1764, 10.1172/JCI59581

Kumar, 2012, TWEAK and TRAF6 regulate skeletal muscle atrophy, Curr. Opin. Clin. Nutr. Metab. Care, 15, 233, 10.1097/MCO.0b013e328351c3fc

Lai, 2004, Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy, Mol. Cell. Biol., 24, 9295, 10.1128/MCB.24.21.9295-9304.2004

Laplante, 2012, mTOR signaling in growth control and disease, Cell, 149, 274, 10.1016/j.cell.2012.03.017

Lecker, 2006, Protein degradation by the ubiquitin-proteasome pathway in normal and disease states, J. Am. Soc. Nephrol., 17, 1807, 10.1681/ASN.2006010083

Lee, 2004, Regulation of muscle mass by myostatin, Annu. Rev. Cell Dev. Biol., 20, 61, 10.1146/annurev.cellbio.20.012103.135836

Lee, 2007, Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways, PLoS ONE, 2, e789, 10.1371/journal.pone.0000789

Lee, 2011, Atrogin1/MAFbx: what atrophy, hypertrophy, and cardiac failure have in common, Circ. Res., 109, 123, 10.1161/CIRCRESAHA.111.248872

Lee, 1999, Myostatin and the control of skeletal muscle mass, Curr. Opin. Genet. Dev., 9, 604, 10.1016/S0959-437X(99)00004-0

Lee, 2001, Regulation of myostatin activity and muscle growth, Proc. Natl. Acad. Sci. USA, 98, 9306, 10.1073/pnas.151270098

Lee, 2004, Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase, J. Am. Soc. Nephrol., 15, 1537, 10.1097/01.ASN.0000127211.86206.E1

Lee, 2010, Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies, Science, 327, 1223, 10.1126/science.1182228

Levine, 2008, Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans, N. Engl. J. Med., 358, 1327, 10.1056/NEJMoa070447

Li, 2004, Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex, J. Clin. Invest., 114, 1058, 10.1172/JCI200422220

Liu, 2007, Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia mice, Cancer Gene Ther., 14, 945, 10.1038/sj.cgt.7701091

Lokireddy, 2011, Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting, Mol. Endocrinol., 25, 1936, 10.1210/me.2011-1124

Malicdan, 2008, Lysosomal myopathies: an excessive build-up in autophagosomes is too much to handle, Neuromuscul. Disord., 18, 521, 10.1016/j.nmd.2008.04.010

Mammucari, 2007, FoxO3 controls autophagy in skeletal muscle in vivo, Cell Metab., 6, 458, 10.1016/j.cmet.2007.11.001

Masiero, 2010, Autophagy inhibition induces atrophy and myopathy in adult skeletal muscles, Autophagy, 6, 307, 10.4161/auto.6.2.11137

Masiero, 2009, Autophagy is required to maintain muscle mass, Cell Metab., 10, 507, 10.1016/j.cmet.2009.10.008

Massagué, 2005, Smad transcription factors, Genes Dev., 19, 2783, 10.1101/gad.1350705

McCarthy, 2011, Effective fiber hypertrophy in satellite cell-depleted skeletal muscle, Development, 138, 3657, 10.1242/dev.068858

McFarlane, 2006, Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism, J. Cell. Physiol., 209, 501, 10.1002/jcp.20757

McPherron, 1997, Double muscling in cattle due to mutations in the myostatin gene, Proc. Natl. Acad. Sci. USA, 94, 12457, 10.1073/pnas.94.23.12457

McPherron, 1997, Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member, Nature, 387, 83, 10.1038/387083a0

Menconi, 2007, Role of glucocorticoids in the molecular regulation of muscle wasting, Crit. Care Med., 35, S602, 10.1097/01.CCM.0000279194.11328.77

Mieulet, 2007, S6 kinase inactivation impairs growth and translational target phosphorylation in muscle cells maintaining proper regulation of protein turnover, Am. J. Physiol. Cell. Physiol., 293, C712, 10.1152/ajpcell.00499.2006

Minetti, 2011, Gαi2 signaling promotes skeletal muscle hypertrophy, myoblast differentiation, and muscle regeneration, Sci. Signal., 4, ra80, 10.1126/scisignal.2002038

Mittal, 2010, The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice, J. Cell Biol., 188, 833, 10.1083/jcb.200909117

Mizushima, 2004, In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker, Mol. Biol. Cell, 15, 1101, 10.1091/mbc.e03-09-0704

Mizushima, 2008, Autophagy fights disease through cellular self-digestion, Nature, 451, 1069, 10.1038/nature06639

Monier, 1983, Insulin and insulin-like growth factor I. Effects on protein synthesis in isolated muscles from lean and goldthioglucose-obese mice, Diabetes, 32, 392, 10.2337/diab.32.5.392

Moresi, 2010, Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases, Cell, 143, 35, 10.1016/j.cell.2010.09.004

Moresi, 2012, Histone deacetylases 1 and 2 regulate autophagy flux and skeletal muscle homeostasis in mice, Proc. Natl. Acad. Sci. USA, 109, 1649, 10.1073/pnas.1121159109

Morissette, 2006, Myostatin regulates cardiomyocyte growth through modulation of Akt signaling, Circ. Res., 99, 15, 10.1161/01.RES.0000231290.45676.d4

Mourkioti, 2006, Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration, J. Clin. Invest., 116, 2945, 10.1172/JCI28721

Musarò, 2001, Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle, Nat. Genet., 27, 195, 10.1038/84839

Nakashima, 2007, AMPK activation stimulates myofibrillar protein degradation and expression of atrophy-related ubiquitin ligases by increasing FOXO transcription factors in C2C12 myotubes, Biosci. Biotechnol. Biochem., 71, 1650, 10.1271/bbb.70057

Narendra, 2011, Targeting mitochondrial dysfunction: role for PINK1 and Parkin in mitochondrial quality control, Antioxid. Redox Signal., 14, 1929, 10.1089/ars.2010.3799

Novak, 2010, Nix is a selective autophagy receptor for mitochondrial clearance, EMBO Rep., 11, 45, 10.1038/embor.2009.256

Orciuolo, 2007, Unexpected cardiotoxicity in haematological bortezomib treated patients, Br. J. Haematol., 138, 396, 10.1111/j.1365-2141.2007.06659.x

Paik, 2007, FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis, Cell, 128, 309, 10.1016/j.cell.2006.12.029

Pankiv, 2007, p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy, J. Biol. Chem., 282, 24131, 10.1074/jbc.M702824200

Park, 2009, Autophagic degradation of nuclear components in mammalian cells, Autophagy, 5, 795, 10.4161/auto.8901

Paul, 2010, Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice, J. Cell Biol., 191, 1395, 10.1083/jcb.201006098

Paul, 2012, The E3 ubiquitin ligase TRAF6 intercedes in starvation-induced skeletal muscle atrophy through multiple mechanisms, Mol. Cell. Biol., 32, 1248, 10.1128/MCB.06351-11

Peng, 2003, Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2, Genes Dev., 17, 1352, 10.1101/gad.1089403

Peterson, 2011, NF-κB signaling in skeletal muscle health and disease, Curr. Top. Dev. Biol., 96, 85, 10.1016/B978-0-12-385940-2.00004-8

Piétri-Rouxel, 2010, DHPR alpha1S subunit controls skeletal muscle mass and morphogenesis, EMBO J., 29, 643, 10.1038/emboj.2009.366

Puigserver, 2003, Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction, Nature, 423, 550, 10.1038/nature01667

Raben, 2008, Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease, Hum. Mol. Genet., 17, 3897, 10.1093/hmg/ddn292

Raffaello, 2010, JunB transcription factor maintains skeletal muscle mass and promotes hypertrophy, J. Cell Biol., 191, 101, 10.1083/jcb.201001136

Ramachandran, 2009, VMA21 deficiency causes an autophagic myopathy by compromising V-ATPase activity and lysosomal acidification, Cell, 137, 235, 10.1016/j.cell.2009.01.054

Reed, 2012, Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy, FASEB J., 26, 987, 10.1096/fj.11-189977

Reisz-Porszasz, 2003, Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin, Am. J. Physiol. Endocrinol. Metab., 285, E876, 10.1152/ajpendo.00107.2003

Risson, 2009, Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy, J. Cell Biol., 187, 859, 10.1083/jcb.200903131

Romanello, 2010, Mitochondrial biogenesis and fragmentation as regulators of muscle protein degradation, Curr. Hypertens. Rep., 12, 433, 10.1007/s11906-010-0157-8

Romanello, 2010, Mitochondrial fission and remodelling contributes to muscle atrophy, EMBO J., 29, 1774, 10.1038/emboj.2010.60

Rommel, 2001, Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways, Nat. Cell Biol., 3, 1009, 10.1038/ncb1101-1009

Sacheck, 2004, IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1, Am. J. Physiol. Endocrinol. Metab., 287, E591, 10.1152/ajpendo.00073.2004

Sacheck, 2007, Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases, FASEB J., 21, 140, 10.1096/fj.06-6604com

Sandri, 2004, Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy, Cell, 117, 399, 10.1016/S0092-8674(04)00400-3

Sandri, 2006, PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription, Proc. Natl. Acad. Sci. USA, 103, 16260, 10.1073/pnas.0607795103

Sartorelli, 2004, Molecular and cellular determinants of skeletal muscle atrophy and hypertrophy, Sci. STKE, 2004, re11, 10.1126/stke.2442004re11

Sartori, 2009, Smad2 and 3 transcription factors control muscle mass in adulthood, Am. J. Physiol. Cell Physiol., 296, C1248, 10.1152/ajpcell.00104.2009

Schakman, 2008, Mechanisms of glucocorticoid-induced myopathy, J. Endocrinol., 197, 1, 10.1677/JOE-07-0606

Schiaffino, 1972, Studies on the effect of denervation in developing muscle. II. The lysosomal system, J. Ultrastruct. Res., 39, 1, 10.1016/S0022-5320(72)80002-9

Schiaffino, 2011, Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models, Skelet. Muscle, 1, 4, 10.1186/2044-5040-1-4

Schuelke, 2004, Myostatin mutation associated with gross muscle hypertrophy in a child, N. Engl. J. Med., 350, 2682, 10.1056/NEJMoa040933

Schulze, 2005, Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction, Circ. Res., 97, 418, 10.1161/01.RES.0000179580.72375.c2

Senf, 2011, p300 Acetyltransferase activity differentially regulates the localization and activity of the FOXO homologues in skeletal muscle, Am. J. Physiol. Cell Physiol., 300, C1490, 10.1152/ajpcell.00255.2010

Shi, 2011, The SCF-Fbxo40 complex induces IRS1 ubiquitination in skeletal muscle, limiting IGF1 signaling, Dev. Cell, 21, 835, 10.1016/j.devcel.2011.09.011

Shimizu, 2011, Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle, Cell Metab., 13, 170, 10.1016/j.cmet.2011.01.001

Song, 2005, Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting, J. Clin. Invest., 115, 451, 10.1172/JCI22324

Southgate, 2007, FOXO1 regulates the expression of 4E-BP1 and inhibits mTOR signaling in mammalian skeletal muscle, J. Biol. Chem., 282, 21176, 10.1074/jbc.M702039200

Stitt, 2004, The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors, Mol. Cell, 14, 395, 10.1016/S1097-2765(04)00211-4

Sundaram, 2009, USP19-deubiquitinating enzyme regulates levels of major myofibrillar proteins in L6 muscle cells, Am. J. Physiol. Endocrinol. Metab., 297, E1283, 10.1152/ajpendo.00409.2009

Supinski, 2009, Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction, Am. J. Physiol. Lung Cell Mol. Physiol., 296, L994, 10.1152/ajplung.90404.2008

Suzuki, 2007, NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS, J. Clin. Invest., 117, 2468, 10.1172/JCI30654

Takano, 2010, Nebulin and N-WASP cooperate to cause IGF-1-induced sarcomeric actin filament formation, Science, 330, 1536, 10.1126/science.1197767

Takikita, 2010, Fiber type conversion by PGC-1α activates lysosomal and autophagosomal biogenesis in both unaffected and Pompe skeletal muscle, PLoS ONE, 5, e15239, 10.1371/journal.pone.0015239

Tanaka, 2000, Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice, Nature, 406, 902, 10.1038/35022595

Tintignac, 2005, Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase, J. Biol. Chem., 280, 2847, 10.1074/jbc.M411346200

Trendelenburg, 2009, Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size, Am. J. Physiol. Cell Physiol., 296, C1258, 10.1152/ajpcell.00105.2009

Vergne, 2009, Control of autophagy initiation by phosphoinositide 3-phosphatase Jumpy, EMBO J., 28, 2244, 10.1038/emboj.2009.159

Waddell, 2008, The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene, Am. J. Physiol. Endocrinol. Metab., 295, E785, 10.1152/ajpendo.00646.2007

Wenz, 2009, Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging, Proc. Natl. Acad. Sci. USA, 106, 20405, 10.1073/pnas.0911570106

Wing, 1991, Proteins containing peptide sequences related to Lys-Phe-Glu-Arg-Gln are selectively depleted in liver and heart, but not skeletal muscle, of fasted rats, Biochem. J., 275, 165, 10.1042/bj2750165

Witt, 2008, Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2, EMBO J., 27, 350, 10.1038/sj.emboj.7601952

Wohlgemuth, 2010, Skeletal muscle autophagy and apoptosis during aging: effects of calorie restriction and life-long exercise, Exp. Gerontol., 45, 138, 10.1016/j.exger.2009.11.002

Wu, 1999, Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC- 1, Cell, 98, 115, 10.1016/S0092-8674(00)80611-X

Youle, 2011, Mechanisms of mitophagy, Nat. Rev. Mol. Cell Biol., 12, 9, 10.1038/nrm3028

Zhou, 2010, Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival, Cell, 142, 531, 10.1016/j.cell.2010.07.011

Zimmers, 2002, Induction of cachexia in mice by systemically administered myostatin, Science, 296, 1486, 10.1126/science.1069525